] Filters: Keyword is Glioblastoma [Clear All Filters]
"Microfluidic-Derived Docosahexaenoic Acid Liposomes for Targeting Glioblastoma and Its Inflammatory Microenvironment",
Acs Applied Materials & Interfaces, doi:10.1021/acsami.4c01368, 2024.
"The Potential of the Fibronectin Inhibitor Arg-Gly-Asp-Ser in the Development of Therapies for Glioblastoma",
Int. J. Mol. Sci., vol. 25, pp. 4910, 2024.
"Oxygen tension modulates cell function in an in vitro three-dimensional glioblastoma tumor model",
Bio-Design and Manufacturing, doi:0.1007/s42242-024-00271-9, 2024.
"Microfluidic-derived docosahexaenoic acid liposomes for glioblastoma therapy",
Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 53, pp. 102704, doi:10.1016/j.nano.2023.102704, 2023.
"Macrophage cell membrane infused biomimetic liposomes for glioblastoma targeted therapy",
Nanomedicine: Nanotechnology, Biology and Medicine, vol. 49, pp. 102663, 2023.
"Efficacy of molecular and nano-therapies on brain tumor models in microfluidic devices",
Biomaterials Advances, vol. 144, pp. 213227, doi:10.1016/j.bioadv.2022.213227, 2023.
"Biomimetic and cell-based nanocarriers - New strategies for brain tumor targeting",
Journal of Controlled Release, vol. 337, pp. 482-493, doi:10.1016/j.jconrel.2021.07.047, 2021.
"A New Chalcone Derivative with Promising Antiproliferative and Anti-Invasion Activities in Glioblastoma Cells",
Molecules, vol. 26, issue 11, pp. 3383, doi:10.3390/molecules26113383, 2021.
"In vitro evaluation of the cytotoxicity and cellular uptake of CMCht/PAMAM dendrimer nanoparticles by glioblastoma cell models",
Journal of Nanoparticle Research (NANO), doi:10.1007/s11051-013-1621-6, 2013.
